Objective To evaluate three commercial typhoid rapid antibody tests for Salmonella Typhi antibodies in patients suspected of having typhoid fever in Mpumalanga, South Africa, and Moshi, United Republic of Tanzania. 
Introduction
Typhoid fever remains an important cause of disease in developing countries. In 2002, it caused an estimated 408 837 episodes of illness in Africa.
1 Salmonella Typhi, the causative agent, is most frequently isolated from blood during the first week of illness but can also be isolated during the second or third week of illness, during the first week of antimicrobial therapy and during clinical relapse. 2 
Isolation of Salmonella
Typhi from bone marrow is the current gold standard method for confirming a case of typhoid fever. However, this requires equipment, supplies and trained laboratory personnel seldom found in primary health-care facilities in the developing world. 3, 4 Blood culture is a more practical albeit less sensitive alternative to bone marrow culture. However, it is not always available and, when it is, it takes 2 to 3 days. As a result, diagnosis may be delayed or overlooked and patients without typhoid fever may receive unnecessary and inappropriate antimicrobial treatment. For this reason, in developing countries typhoid rapid antibody tests can facilitate diagnosis and disease management.
New commercially available typhoid rapid antibody tests have been evaluated in Asia, where typhoid fever is known to be highly endemic. 1, 5 In Asian studies the tests have shown variable performance. While the TUBEX ® test was the most sensitive and specific in the Philippines, 6 neither TUBEX ® nor Typhidot ® was both sensitive and specific in two evaluations undertaken in Viet Nam 7, 8 and performance was poor in a trial conducted in a community clinic in Bangladesh 9 and in a study in Egypt in which it was compared with a new ELISA not yet commercially available. 10 Rapid typhoid tests have not been evaluated in sub-Saharan Africa, where the typhoid fever burden may be smaller than in Asia. [11] [12] [13] The World Health Organization (WHO) has issued no recommendations on the use of typhoid rapid antibody tests.
14 Accurate diagnostics for typhoid fever could provide valuable diagnostic information for patient management and make it possible to the estimate the incidence of typhoid fever in low-resource settings.
We evaluated three diagnostic kits that are commercially available internationally using four rapid methods for detecting antibodies to Salmonella Typhi (typhoid rapid antibody tests) and used blood culture as the standard for comparison.
Methods

Participants
Patients were recruited from two sub-Saharan African sites: Mpumalanga province, South Africa, and Moshi, United Republic of Tanzania. They were selected to represent patients from southern and eastern Africa, respectively.
The recruitment method differed between sites. In South Africa, we enrolled subjects suspected of having typhoid fever; in the United Republic of Tanzania, we enrolled patients who were participants in a study on the etiology of febrile illness. Regional Hospital. 15, 16 At both sites we incubated the blood in a continuously monitored blood culture system (Bac-T Alert, bioMérieux, Marcy L'Étoile, France).
Bottles flagged as positive by the instrument were removed for subculture and identification by standard techniques. 17 In both study sites, we enrolled patients who presented with a febrile illness suspected of being typhoid fever. We collected data on those patients who fulfilled the clinical criteria for suspected typhoid fever (a history or fever or demonstrated pyrexia [body temperature > 38 °C.]) before performing the index test and blood culture.
Test methods
In both study sites a typhoid fever case was defined as being a patient whose blood culture was positive for Salmonella Typhi. Patients whose blood cultures were negative or yielded pathogens other than Salmonella Typhi were used as controls. We drew additional blood and separated the serum, which was stored at 20 or 80 °C in cryotubes and shipped on dry ice to the Enteric Diseases Reference Unit, National Seattle, USA). Stata's diagt command was used to determine each test's sensitivity, specificity and positive and negative predictive values (PPV and NPV, respectively), 22 which are presented with the understanding that exposure to antimicrobials could have affected the final results. Analysis was performed at a two-sided significance level of 5%. Pre-test probabilities of background typhoid fever rates were also calculated at 5% and 50% to ensure that the results were applicable even in conditions of few typhoid fever outbreaks -since incidence would be higher during outbreaks -and of lower endemicity, given that study patients were selected on the probability of having typhoid fever.
Research ethics
The NICD has blanket ethics clearance in relationship to its surveillance duties (M06- 
Test results
Blood cultures were done as soon as patients were admitted to hospital. Serological tests were performed within the subsequent 6 months at the South African site and within 2 years at the Tanzanian site. Table 3 .
Discussion
All four typhoid rapid antibody tests performed poorly compared with blood culture.
Some tests performed better than others, but none stood out in all respects. In sub- The single-tube Widal agglutination test also performed poorly. The original Widal agglutination test was described using paired sera obtained 10 days to 2 weeks apart and examined for a twofold or greater change in titre. 18 It is possible that the Widal test would have performed better in our study had we used paired sera, but we chose to apply the test under the conditions normally found in clinical practice. In our experience, patients rarely return for outpatient follow-up once treated, so that obtaining paired sera in a routine clinical setting is unlikely. Recently, the use of paired sera has been re-examined and has been shown to improve both the sensitivity and specificity of serological tests for typhoid fever. 24 Both the TUBEX ® and Typhidot ® tests had lower sensitivity than the semiquantitative slide agglutination and the Widal tests, but they had considerably greater specificity. In our setting, TUBEX ® had marginally less sensitivity but more specificity than the Typhidot ® IgM test and it had a slightly better PPV. Typhidot IgG was comparable to TUBEX ® with respect to sensitivity, specificity and PPV, but none of these tests performed as well as the blood culture comparator assay.
This study had several limitations. Typhoid fever was confirmed by blood culture in almost one third of the study participants, a much larger proportion than expected under field conditions in sub-Saharan Africa, where typhoid fever is relatively uncommon. 12, 13 Lowering the pre-test probability for typhoid fever to 5%
further degraded the performance characteristics of the typhoid rapid antibody tests (Table 3) , which suggests that these tests would not be useful in routine diagnostic situations. At a pre-test probability of 50%, higher than the actual fraction of bloodculture-positive cases used in this evaluation, the performance of the new rapid antibody tests improved. Hence, these tests can perhaps be judiciously used during outbreaks.
The time elapsed between the onset of symptoms and serum collection can affect the performance of antibody-based tests. 25 We did not analyse this aspect to reflect how the tests would be used under routine health-care conditions in subSaharan Africa. Similarly, human immunodeficiency virus (HIV) infection is highly prevalent in sub-Saharan Africa 26 and we enrolled participants without reference to their HIV serostatus to reflect field conditions, although many of our patients could have been HIV-infected. HIV infection rates among 1504 adult outpatients tested in Nelspruit (RFH) were reportedly as high as 45% in 2010 (G Hoyland, personal communication). The prevalence of HIV infection among participants in the study on febrile illness at KCMC and Mawenzi Regional Hospital was 39% for adolescents and adults and 12% for infants and children. 15, 16 Although recent studies at KCMC have
shown that HIV appears to protect against typhoid fever, disease may still occur in HIV-infected individuals. 15 It is possible that HIV-associated immune dysregulation affects the production of antibodies specific to Salmonella Typhi outer membrane proteins, present in both the Typhidot ® and the older Widal tests. This has been observed in patients infected with invasive non-typhoidal Salmonella (NTS). 27 This theoretical effect can also impair antibody binding in the TUBEX ® test, which is based on the O9 antigen. The production of antibodies against Salmonella lipopolysaccharide (LPS) is increased in patients with invasive NTS infection who are also HIV-infected. If antibody production were also higher in HIV+ typhoid fever Publication: Bulletin of the World Health Organization; Type: Research Article ID: BLT.11.087627 patients, TUBEX ® would have performed better than the other typhoid rapid antibody tests, but it did not.
The sensitivity of blood culture is known to be less than 100%, even in the absence of antimicrobial exposure, and is further reduced by patient antimicrobial use.
Although two Tanzanian patients had been exposed to antibacterials, they represented only 3.8% of the 52 patients whose blood cultures were negative for Salmonella
Typhi. These patients probably affected our results very little. Furthermore, blood culture sensitivity was optimized in our study because we used modern blood culture techniques. 28 Our findings on the Widal test and the newer typhoid rapid antibody tests are similar to those from studies conducted in Asia and Egypt [8] [9] [10] 25, 29, 30 ; none of the rapid tests performed nearly as well as blood culture for the diagnosis of typhoid fever.
Some reports suggest that the Typhidot ® test may be more useful in Asia. 31, 32 However, the true incidence of typhoid fever in the catchment population differed in these studies and in ours. The pre-test probability of typhoid fever was artificially elevated in our evaluation because we included South African patients suspected of having typhoid fever and specifically analysed a subset of antisera from the United Republic of Tanzania in which half of the cases were known to have typhoid fever.
The earlier studies also focused on paediatric populations and allowed for inclusion of microbiologically unconfirmed typhoid fever. 31, 32 NTS bacteraemia, which is predominantly caused by Salmonella serotypes Typhimurium and Enteritidis, is much more common in sub-Saharan Africa than typhoid fever. 12, 13 An important limitation of our study is the absence of cases of NTS in the control group; one patient in our study had Salmonella Typhimurium bacteraemia and none had Salmonella Enteritidis bacteraemia. It has been observed in previous studies that bacteraemia due to Salmonella Enteritidis may result in falsepositive results with TUBEX ® because they have an O9 antigen in common. 33 Although the patient with Salmonella Typhimurium had negative typhoid rapid antibody tests, we could not examine the rate of false positives for the TUBEX ® test in patients with Salmonella Enteritidis bacteraemia.
In conclusion, typhoid rapid antibody tests appear to correlate poorly with blood culture results in sub-Saharan Africa, even in a study with inflated pre-test 
